Gemini Therapeutics, Inc. ($GMTX)
Franchi Jean M. โ Chief Financial Officer
Shares
3,684
Price
$65.89
Total Value
$242,734.71
Nearby Earnings
Feb 26, 2026
EPS:Est: -1.71
Transaction Details
| Insider | Franchi Jean M. |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Sold | 3,684 |
| Price per Share | $65.89 |
| Total Value | $242,734.71 |
| Shares Owned After | 71,343 |
| Derivative | No |
| Accession Number | 0001193125-26-059760 |
| Document | View SEC Filing |